The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
- 
      
  
Rapid Response Innovation Awards, 2009Defining Genetic Factors for PD in a Conserved PopulationObjective/Rationale: 
 The identification of genes underlying risk for Parkinson’s disease (PD) helps to further the understanding of this complex disorder, with the discovery of new genes contributing...
- 
      
  
MJFF Research Grant, 2010Generating and Characterizing LRRK2 AntibodiesObjective/Rationale: 
 LRRK2 is a gene implicated in the development of some familial Parkinson’s disease cases. Because of LRRK2’s significant potential as a drug target, MJFF is making considerable...
- 
      
  
Program-non-specific Funding, 2009Data Repository for Experimental DataObjective/Rationale: 
 Synthesizing biomedical data into effective discoveries is greatly hampered by the way science is both reported in research articles and stored in databases. Articles do not...
- 
      
  
MJFF Research Grant, 2010Comparison and Actions of MANF and GDNF in Rodent Models of Parkinson's DiseaseObjective/Rationale: 
 Parkinson's disease (PD) is caused by the degeneration of certain dopaminergic neurons in the brain. Neurotrophic factors like GDNF protect dopaminergic neurons from degenerating...
- 
      
  
MJFF Research Grant, 2010Viral Over-expression of Alpha SynucleinPromising Outcomes of Original Grant: 
 In our previous grant, we attempted to create a bilateral model of PD using viral over expression of alpha-synuclein. The performance of the study was near...
- 
      
  
MJFF Research Grant, 2010A Rodent Model of Pathological Gambling Associated with Medicated Parkinsonian PatientsPromising Outcomes of Original Grant: 
 In keeping with our original hypothesis, we determined the following: 1) Being in a parkinsonian state (i.e., following 6-OHDA-induced lesions) alters impulsivity...
 
  Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.